2014-12-03
Progress with Drug-Eluting Stent Technology from Early to New Generation Devices
Publication
Publication
A comprehensive clinical and intravascular imaging evaluation
De vooruitgang in medicijn-eluerende stenttechnologie van vroege- naar nieuwe generatie stents: Een uitgebreide evaluatie middels klinische en intravasculaire beeldvorming
Abstract
Percutaneous coronary interventions (PCI) are among the most frequently performed medical interventions worldwide reflecting the large burden of coronary atherosclerosis. Bare metal stents were associated with a high rate of repeat revascularization due to clinical instent-restenosis in up to 15-20% of patients. With the introduction of early generation drug-eluting stents, clinical restenosis was significantly reduced to approximately 5% at one year. This effect was consistent among a wide variety of patient and lesion subsets so that the use of DES was recommended by guidelines.
| Additional Metadata | |
|---|---|
| , , , | |
| P.W.J.C. Serruys (Patrick) , S.W. Windecker (Stephan) | |
| Erasmus University Rotterdam | |
| Financial support by Biosensors SA, Morges, Switzerland, and St. Jude Medical, Zurich, Switzerland, and Cardialysis B.V., Rotterdam, The Netherlands Layout and printing: Optima Communicatie, Rotterdam, The Netherlands | |
| hdl.handle.net/1765/77216 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Räber, L. (2014, December 3). Progress with Drug-Eluting Stent Technology from Early to New Generation Devices. Retrieved from http://hdl.handle.net/1765/77216 |
|
